Life Sciences Tools & Services Companies By Roe

Return On Equity
ROEEfficiencyMarket RiskExp Return
1MEDP Medpace Holdings
0.54
 0.00 
 2.94 
 0.00 
2WAT Waters
0.5
 0.08 
 2.95 
 0.24 
3MTD Mettler Toledo International
0.3
(0.08)
 1.95 
(0.16)
4A Agilent Technologies
0.25
 0.00 
 1.63 
 0.00 
5IQV IQVIA Holdings
0.22
(0.17)
 1.86 
(0.32)
6BRKR Bruker
0.2
(0.06)
 2.68 
(0.16)
7SHC Sotera Health Co
0.17
(0.09)
 2.46 
(0.21)
8TMO Thermo Fisher Scientific
0.13
(0.17)
 1.24 
(0.21)
9CRL Charles River Laboratories
0.12
 0.03 
 2.58 
 0.09 
10ICLR ICON PLC
0.0799
(0.16)
 3.45 
(0.56)
11TECH Bio Techne Corp
0.0729
 0.05 
 2.35 
 0.11 
12AVTR Avantor
0.0581
(0.18)
 1.47 
(0.27)
13CDXC Chromadex Corp
0.0482
 0.18 
 9.18 
 1.67 
14RVTY Revvity
0.0331
(0.02)
 1.64 
(0.03)
15QGEN Qiagen NV
0.0257
(0.02)
 1.26 
(0.02)
16CDT Conduit Pharmaceuticals
0.0
 0.01 
 8.06 
 0.05 
17TEM Tempus AI, Class
0.0
 0.07 
 8.04 
 0.59 
18AFJK Aimei Health Technology
0.0
 0.10 
 0.22 
 0.02 
19AXDX Accelerate Diagnostics
0.0
(0.06)
 4.04 
(0.24)
20CTOR Citius Oncology,
0.0
(0.12)
 6.53 
(0.76)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income. For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.